Retour sur lavenir.net
   DEME GROUP 169.000 € (+0,12 %)     CELYAD ONCOLOGY 0.250 € (-9,42 %)     WDP 22.400 € (+1,36 %)     AB INBEV 72.520 € (+1,45 %)     VGP 82.700 € (+1,97 %)     FAGRON 23.700 € (-0,63 %)     ENERGYVISION 14.840 € (+0,27 %)     XIOR 27.950 € (0,00 %)     NYXOAH 1.368 € (-1,16 %)     ELIA GROUP 139.800 € (+1,60 %)     KBC 122.650 € (+0,25 %)     BPOST 1.560 € (-0,64 %)     ORANGE BELGIUM 21.800 € (+0,46 %)     TESSENDERLO 20.900 € (+1,95 %)     ECONOCOM GROUP 1.465 € (0,00 %)     COLRUYT 38.120 € (+0,47 %)     ONTEX GROUP 2.265 € (+2,49 %)     CFE 11.500 € (+0,44 %)     IBA 16.680 € (-0,36 %)     VIOHALCO 17.680 € (+2,67 %)     TEXAF 40.400 € (-2,42 %)     SHURGARD 25.550 € (+1,39 %)     KBC ANCORA 87.100 € (-0,11 %)     UCB 243.300 € (-0,25 %)     TINC 11.340 € (+1,80 %)     CIE BOIS SAUVAGE 310.000 € (+2,99 %)     FLUXYS BELGIUM D 20.000 € (+2,56 %)     SOLVAY 26.140 € (+0,62 %)     SOLVAC NOM(RETAIL) 77.500 € (+3,33 %)     PROXIMUS 6.135 € (+1,24 %)     AGFA-GEVAERT 0.400 € (+1,39 %)     GBL 77.850 € (+0,84 %)     ONWARD MEDICAL 2.475 € (-0,40 %)     SIPEF 93.900 € (+1,62 %)     ACKERMANS V.HAAREN 269.800 € (+0,45 %)     JENSEN-GROUP 85.800 € (+1,90 %)     CENERGY 21.560 € (+1,41 %)     BELYSSE GROUP 0.510 € (+6,25 %)     AGEAS 72.050 € (+1,77 %)     TUBIZE-FIN 210.000 € (+0,48 %)     VAN DE VELDE 30.100 € (+1,69 %)     HOME INVEST BE. 19.860 € (+2,06 %)     BREDERODE 103.000 € (0,00 %)     WERELDHAVE BELGIUM 53.200 € (+1,53 %)     VASTNED 29.400 € (+0,34 %)     ARGENX SE 758.400 € (-0,24 %)     AEDIFICA 70.400 € (+0,72 %)     RECTICEL 12.120 € (+0,83 %)     CAMPINE 207.000 € (+0,49 %)     AZELIS GROUP 10.480 € (-0,29 %)     ASCENCIO 51.600 € (+0,19 %)     GIMV 44.850 € (+0,67 %)     D'IETEREN GROUP 176.000 € (+2,09 %)     RETAIL ESTATES 68.500 € (+1,33 %)     EVS 27.000 € (+0,37 %)     BARCO 8.000 € (+2,63 %)     DECEUNINCK 2.190 € (+0,69 %)     SYENSQO 69.700 € (+0,58 %)     SOFINA 233.800 € (+2,01 %)     TITAN S.A. 50.700 € (+3,89 %)  
   SAFRAN 327.300 € (+1,36 %)     BNP PARIBAS ACT.A 106.780 € (+1,54 %)     PLANISWARE 20.050 € (+0,25 %)     PROSUS 37.110 € (-3,60 %)     CRCAM MORBIHAN CCI 110.000 € (-0,09 %)     ENGIE 27.560 € (+1,96 %)     SOCIETE GENERALE 78.060 € (+1,11 %)     BE SEMICONDUCTOR 248.100 € (+3,59 %)     ALFEN 13.550 € (-1,38 %)     TIKEHAU CAPITAL 17.300 € (-0,35 %)     ARTMARKET COM 2.600 € (+11,11 %)     PERNOD RICARD 63.140 € (+0,86 %)     EXOSENS 61.950 € (+2,57 %)     EUROPLASMA 0.001 € (-16,67 %)     SCHNEIDER ELECTRIC 269.000 € (+0,07 %)     ABIONYX PHARMA 1.920 € (+3,00 %)     STELLANTIS NV 5.092 € (+0,20 %)     AIR LIQUIDE 176.740 € (+0,12 %)     STMICROELECTRONICS 58.270 € (+1,78 %)     GRAINES VOLTZ 18.000 € (-0,83 %)     ASM INTERNATIONAL 895.400 € (-0,80 %)     GROUPE OKWIND 0.215 € (-10,42 %)     CROSSJECT 1.544 € (-2,03 %)     MICHELIN 35.010 € (-0,14 %)     ACCOR 46.290 € (-0,15 %)     ASML HOLDING 1 589.600 € (-0,24 %)     WOLTERS KLUWER 59.980 € (-0,03 %)     CARREFOUR 16.650 € (+0,63 %)     TOTALENERGIES 74.290 € (+2,03 %)     ING GROEP N.V. 29.215 € (+0,53 %)     CVC CAPITAL 14.300 € (-0,83 %)     ELIS 25.400 € (+0,79 %)     ADYEN 820.900 € (+0,04 %)     AKZO NOBEL 58.140 € (+1,71 %)     LVMH 474.000 € (-0,95 %)     HERMES INTL 1 679.500 € (-0,09 %)     AIRBUS 208.300 € (+7,04 %)     REXEL 38.210 € (+0,26 %)     LARGO 1.520 € (+4,11 %)     UNILEVER 54.090 € (+1,22 %)     KERING 250.750 € (-0,08 %)     CHRISTIAN DIOR 440.000 € (0,00 %)     RELX 28.880 € (-0,07 %)     RAPID NUTRITION 4.070 € (+13,69 %)     ABIVAX 115.400 € (-1,79 %)     BUREAU VERITAS 27.220 € (+0,59 %)     JCDECAUX 22.140 € (+1,28 %)     L'OREAL 380.650 € (+0,50 %)     FUGRO 9.785 € (+1,19 %)     TELEPERFORMANCE 54.260 € (+1,76 %)     QUADIENT 12.880 € (+0,94 %)     AEGON 8.074 € (+0,67 %)     GTT 192.000 € (+1,27 %)     VALEO 13.310 € (+2,11 %)     AMUNDI 87.900 € (-1,18 %)     DASSAULT SYSTEMES 17.760 € (-0,89 %)     FRANCAISE ENERGIE 27.150 € (-6,38 %)     MAGNUM 15.884 € (+0,43 %)     WORLDLINE 10.050 € (-1,08 %)     ARVERNE GROUP 8.960 € (-0,44 %)  
News Réglementées
08/07/2026 09:00

Original-Research: Emerald Horizon AG (von NuWays AG): BUY

Original-Research: Emerald Horizon AG - from NuWays AG

08.07.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Emerald Horizon AG

Company Name:Emerald Horizon AG
ISIN:AT0000A3UZE1
 
Reason for the research:Initiation
Recommendation:BUY
Target price:EUR 1300
Target price on sight of:12 months
Last rating change:
Analyst:Jorge Gonzalez

Accelerating the future of clean energy; INITIATE with BUY

Emerald Horizon is an Austrian deep-tech energy infrastructure company
developing a dual-track platform designed to address the growing need for reliable, carbon-free and dispatchable energy. The company combines two complementary technologies: DUALstore PLUS, a modular hybrid energy storage platform integrating battery and thermal storage, and ADES (Accelerator Driven Energy Source), a subcritical thorium-based energy system intended to provide heat, while also enabling carbon-free electricity generation and hydrogen production through downstream conversion technologies. Both platforms are designed to be deployed under long-term Energy-as-a-Service (EaaS) contracts, allowing customers to access energy infrastructure without upfront capital expenditure while providing Emerald with recurring contractual cash flows.

The investment case sits at the intersection of two powerful structural themes: the rapid expansion of energy storage and the emerging market for next-generation nuclear technologies. While the Small Modular Reactor (SMR) industry has attracted substantial investor interest as governments and industry seek scalable carbon-free baseload power, most developers remain focused on electricity generation alone. Emerald's strategy is broader, combining energy storage, industrial heat and power generation within a single commercial platform. Through the integration of DUALstore PLUS and ADES, management aims to address multiple energy-transition challenges, including grid flexibility, industrial decarbonisation, data-centre demand and long-term energy security.

A key differentiator is ADES's proposed subcritical accelerator-driven design. If successfully validated, the architecture could offer several advantages over conventional SMRs, including enhanced safety characteristics, minimal long-lived transuranic waste, lower-cost and more abundant thorium fuel, and a potentially more favourable regulatory and financing profile. Taken together, these features could support a differentiated positioning within the advanced-nuclear landscape, particularly for applications requiring modular or micro-modular, dispatchable and carbon-free energy, while leveraging a subcritical architecture that differs from most conventional SMR designs.

Emerald is entering the most important phase of its development roadmap. Following years focused on technology development, industrial partnerships and validation of its EaaS model, the company is preparing for commercial deployment of DUALstore while advancing ADES toward prototype completion. The public listing represents an important milestone in this process, potentially expanding access to capital while increasing visibility among customers, financing partners and institutional investors. Management's strategy is to establish a contracted customer base through storage deployments before attaching ADES generation modules to existing customer relationships, thereby reducing customer-acquisition risk and improving future project bankability.

We initiate coverage with a BUY and a PT of € 1,300 based on DCF. While execution, financing and regulatory risks remain material, we believe the current valuation primarily reflects expectations surrounding the commercialisation of DUALstore PLUS and only partially captures the longer-term optionality associated with ADES. As a result, successful execution against upcoming technical, commercial and regulatory milestones could support a progressive re-rating of the shares over time. In our view, the current valuation does not fully reflect the long-term earnings potential of Emerald's integrated energy platform.



You can download the research here: emerald-horizon-ag-2026-07-08-fullnoteinitiation-en-b3a97
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2362128  08.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière